Megan Canniere

Route 53 Mimecast Amazon AWS Drupal WP Engine Salesforce Sophos SuccessFactors (SAP) Multilingual Act-On Mobile Friendly Typekit WordPress.org Google Tag Manager Vimeo Bootstrap Framework Google Font API Google Analytics Linkedin Marketing Solutions reCAPTCHA Remote

biotechnology & gene therapy biotechnology: biological products (no diagnostic substances) health care biotechnology research gene therapy aav vectors inherited diseases retinal diseases hemophilia treatment neurodegenerative diseases r&d manufacturing commercial operations regulatory strategies patient care clinical trials therapeutic modalities genetic treatments genomic research personalized medicine investigational therapies life-altering transformations healthcare transformation corporate social responsibility community engagement patient safety ethical practices sustainability environmental impact cross-functional collaboration innovation center biotech manufacturing healthcare professionals genetic conditions drug discovery patient advocacy scientific community genetic disease treatments long-term effects clinical development supply chain management quality assurance patient support programs medicinal innovation compassionate use healthcare equity healthcare accessibility patient-centric approach clinical endpoints genetic diseases rare diseases inherited retinal disorders hemophilia lysosomal storage disorders luxturna fidanacogene elaparvovec spk-8011 spk-7001 spk-3006 spk-1001 adeno-associated viral vector one-time treatments patient-centric innovative therapies pharmaceutical industry partnerships research & development healthcare providers insurance coverage patient outcomes genetic disorder treatment gene therapy innovation center strategic collaborations market access breakthrough therapy designation healthcare innovation health wellness & fitness mechanical or industrial engineering hospital & health care environmental services renewables & environment logistics & supply chain